Skip to main content
Clinical Trials/NCT04276935
NCT04276935
Completed
Not Applicable

Development of a Health-Related Symptom Index for Spanish-Speaking Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

AIDS Malignancy Consortium4 sites in 1 country20 target enrollmentNovember 6, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
High Grade Anal Canal Squamous Intraepithelial Neoplasia
Sponsor
AIDS Malignancy Consortium
Enrollment
20
Locations
4
Primary Endpoint
Development of Spanish-language Version of the Anal Cancer/High-grade Squamous Intraepithelial Lesions (HSIL) Outcomes Research (ANCHOR) Health-related Quality of Life (HRQoL) Index-Round 1 and Round 2
Status
Completed
Last Updated
last year

Overview

Brief Summary

This trial develops a health-related symptom index for participants with and either treated or monitored for anal high-grade squamous intraepithelial lesions. The health-related quality of life index may help to capture the symptoms and related experiences of living with or being treated for high-grade squamous intraepithelial lesions.

Detailed Description

PRIMARY OBJECTIVES: I. To develop a Spanish-language version of the anal cancer/high-grade squamous intraepithelial lesions outcomes research (ANCHOR) high-grade squamous intraepithelial lesions (HSIL) health-related quality of life (HRQoL) index (HQI) using state-of-the-art measure development methodology that captures the most important HRQoL symptoms and concerns of those persons diagnosed with anal HSIL and either treated or untreated for anal HSIL. OUTLINE: Participants take part in cognitive interviews in Spanish over 45-60 minutes.

Registry
clinicaltrials.gov
Start Date
November 6, 2018
End Date
March 1, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
AIDS Malignancy Consortium
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Human immunodeficiency virus (HIV)-1 infection.
  • Biopsy-proven anal HSIL within the prior nine months.
  • Participant must have received anal HSIL treatment in the last nine months. If the participant's treatment plan is observation? the participant must have been diagnosed with anal HSIL in the last nine months.
  • Life expectancy of greater than 5 years.
  • Fluent in Spanish with limited English proficiency, per self-report.

Exclusion Criteria

  • History of anal cancer.
  • Inability to understand a written consent form.

Outcomes

Primary Outcomes

Development of Spanish-language Version of the Anal Cancer/High-grade Squamous Intraepithelial Lesions (HSIL) Outcomes Research (ANCHOR) Health-related Quality of Life (HRQoL) Index-Round 1 and Round 2

Time Frame: 45-60 minutes during the telephone call in each round.

Participants completed A-HRSI, as aurally administered over telephone to indicate whether there were any items or aspects of the instructions that were difficult to understand, and then complete a process of retrospective probing. Summary reports from the Round 1 interview were coded to highlight any instances where a participant indicated that they experienced difficulty with an item or concept within an item. For any item that was reported by at least three participants as difficult for any reason, that item or concept was reviewed to determine whether the difficulty was due to (1) the concept being measured or (2) a translation issue (i.e., register, jargon, or regionalism). These items were revised during a research team panel discussion and used in Round 2 interviews with additional eligible participants. A similar process was used for Round 2.

Study Sites (4)

Loading locations...

Similar Trials